A myocardial infarction is damage to the heart muscle observable through measurable evidence of ischemia, not a subjective sensation. The European Society of Cardiology's congress recently unveiled the fifth universal definition. A group of cardiologists from different countries agreed with clinical precision on exactly what counts as a heart attack: type 1 with plaque rupture, type 2 from an imbalance between oxygen supply and demand, or the procedure-related kind that occurs during an intervention. Three contexts. One shared language. Zero ambiguity for a doctor in Tokyo, Toronto, or Guadalajara. The standardization aims to make a heart attack a heart attack, and the goal is reasonable. When diagnosis varies by country or institution, people pay the price in confusions that treatment can't fix after the fact.
That pursuit of consensus contrasts sharply with what happens in another corner of medicine. There, an observable biological definition exists, and yet agreement is met with suspicion. Man and woman are defined by gametes. Whoever produces eggs is female. Whoever produces sperm is male. The distinction describes a binary reproductive function. No exceptions. Observable. Replicable. Just as stable as the type 1 heart attack category. And yet, while cardiologists from thirty countries fine-tune nuances about coronary plaques without anyone accusing them of ideology, any doctor who repeats the biological definition of sex faces institutional pressure, lawsuits, or the risk of losing their license in certain jurisdictions.
Can biological sex be redefined with the same rigor used to redefine a heart attack? The dominant view holds that this represents progress. That just as cardiology refined the heart attack into subtypes, medicine must recognize that gender exists on a spectrum. That science isn't static. That clinging to obvious definitions amounts to remaining stuck in a primitive understanding of the body. Advocates cite genuine historical corrections. Homosexuality was removed from the DSM in 1973 after decades of real harm caused by a label with no biological basis. Gender dysphoria exists as a documented experience of distress. Those who live it deserve serious clinical attention. Medicine has refined categories before. Up to this point, the argument carries weight.
The analogy breaks down when you examine what's actually being redefined. When the ESC updates the definition of a heart attack, it refines clinical categories within a measurable phenomenon: elevated troponin, imaging of myocardial damage, an electrocardiogram. The three categories don't deny the damaged heart—they simply better organize the causes. Proposing that sex is a subjective spectrum determined by identity, on the other hand, replaces a biological criterion with a psychological one while keeping the same name. It would be absurd in cardiology to define a heart attack by how intensely each patient feels chest pain rather than by measurable muscle damage. In other branches of medicine, this gets presented as progress.
There's an angle rarely mentioned. The disparity already operates—and it's clinically dangerous—within the heart attack diagnosis itself. For years, women were underdiagnosed because the criteria were built largely on data from men. The classic symptoms describe the male presentation well, but many women present with nausea, fatigue, or jaw pain. That bias cost lives. While one part of medicine insists that biological differences between the sexes matter so much they require more study to save lives, another part maintains that those very same differences are negotiable or socially constructed.
Why does the heart attack achieve international consensus at a congress while biological sex can't achieve consensus even within a single country? The answer doesn't lie in the science. It lies in who benefits from each definition. No one gains political, legal, or financial ground by relabeling a type 2 heart attack. Redefining "woman," on the other hand, directly affects competitive sports, locker rooms and shelters, eligibility for hormone treatments, custody litigation, and insurance policy. When a biological definition turns into a legal and political dispute, it stops being an observable fact and becomes a position that must be won. That isn't scientific progress. It's institutional capture dressed up as progress.
Science can evolve in how it treats people without denying what it observes in bodies. One can offer dignity and clinical care to someone living with gender dysphoria without altering the biological definition of sex, just as one can accompany a terminal cancer patient with dignity without redefining death. Clinical compassion and diagnostic precision aren't opposed. They complement each other. When a medical institution confuses the two under external pressure, it ends up failing both. In The Generosity in the Doorway I explore how institutions adopt the vocabulary of updating to justify decisions driven more by pressure than by new evidence. The pattern repeats itself.
I don't have a clean answer for how this should be resolved institutionally. I'm still working through it. What is clear is the uncomfortable asymmetry. We demand mathematical rigor from cardiology to define something as complex as a heart attack, complete with subtypes, biomarkers, and international consensus. At the same time, we accept that other branches of medicine treat as negotiable something that every reproductive biology textbook has described unambiguously for generations. The gamete-based definition of sex is, measured by the same standard, older, more stable, and has fewer exceptions than the definition of heart attack, which has changed five times in less than thirty years.
Skeletal remains found in excavations reveal consistent sexual dimorphism across millennia. The pelvis, the skull, the bone density. Binary. Stones don't lie, but historians sometimes do.
How much scientific rigor are we willing to negotiate away when the pressure comes not from biology, but from somewhere else entirely?
